Literature DB >> 15742616

The use of vaccines in South American foot-and-mouth disease eradication programmes.

V Saraiva1, G Darsie.   

Abstract

Since the beginning of organized campaigns in the 1960s, vaccination has been a major component of national FMD control and eradication programmes in South America. Aqueous vaccines were used in the 1960s and 1970s, and the introduction of oil vaccines in the mid 1980s helped to decrease endemism. Bi- and trivalent FMD vaccine production increased from 266 thousand doses in 1967 to 580 million doses in 2002. Currently, over 200 million cattle are vaccinated twice yearly throughout the continent. This massive vaccination programme, along with outbreak and animal movement control, helped eradicate FMD in sizeable areas in the 1990s. Outbreaks in the Southern Cone during 2000/2001 were curbed mostly by repeated massive vaccination of cattle. The Hemispheric FMD Eradication Plan, with its end date of 2009, relies on cyclic vaccinations as a major instrument. Vaccination as the major component will continue until when?

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15742616

Source DB:  PubMed          Journal:  Dev Biol (Basel)        ISSN: 1424-6074


  3 in total

1.  Elimination of foot-and-mouth disease in South America: lessons and challenges.

Authors:  José Naranjo; Ottorino Cosivi
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-06-24       Impact factor: 6.237

2.  Immunization of DNA vaccine encoding C3d-VP1 fusion enhanced protective immune response against foot-and-mouth disease virus.

Authors:  Huiying Fan; Tiezhu Tong; Huanchun Chen; Aizhen Guo
Journal:  Virus Genes       Date:  2007-05-12       Impact factor: 2.332

3.  Randomised field trial to evaluate serological response after foot-and-mouth disease vaccination in Turkey.

Authors:  T J D Knight-Jones; A N Bulut; S Gubbins; K D C Stärk; D U Pfeiffer; K J Sumption; D J Paton
Journal:  Vaccine       Date:  2014-12-17       Impact factor: 3.641

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.